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Introduction
We describe a case of  systemic connective tissue disease (CTD) 
in a Malawian man in whom an autoimmune etiology was 
likely. Autoimmune CTDs are rarely reported in Africans[2] 
and there have been no case reports from Malawi. We were 
fortunate in that we were able to obtain additional tests on 
this patient including his autoantibody profile and HLA type 
which helped characterise his problem.
Case Presentantion
A 17 year-old student was referred to Queen Elizabeth 
Central Hospital (QECH) for management of  progressive 
breathlessness. At the referring hospital he had been noted 
to have an abnormal chest X-ray (CXR) and had been treated 
for smear negative pulmonary TB (pTB). Having completed 
TB treatment there was no improvement and he was being 
considered for re-treatment for smear negative TB at the 
time of  referral. At this point his case was reviewed.
Breathlessness, which was worse on exertion, had been 
present for 18 months. It was not associated with cough or 
fevers. Joint pain, mainly affecting his hands, developed one 
month after the breathlessness. It was worse in the morning 
and associated with stiffness lasting more than 1 hour daily. 
He had noticed deformity of  his hands. He occasionally had 
dry mouth but denied eye symptoms, Raynauds phenomenon 
or dysphagia. There was no relevant environmental exposure, 
past medical or family history. The only previous medication 
was anti-tuberculous drugs plus paracetamol. He did not 
drink alcohol nor smoke.
On examination he was of  small stature. He had no rashes. 
His eyes and mouth were normal. There was no cyanosis 
or lymphadenopathy and blood pressure was normal. The 
appearance of  his hands is shown in figure 1. The skin 
appeared thickened, shiny and tight with camptodactylia 
(sclerodactylia). There was no cutaneous calcinosis, ulceration 
or telangectasia. The distal phalanges were shortened with 
clubbing and/or pseudoclubbing of  the nails. He had 
swelling and deformity of  the wrists but other large joints 
appeared normal. Chest expansion was reduced bilaterally 
and auscultation was normal. His spleen was palpable 4cm 
below the costal margin.
X rays of  the hands are shown in Figure 2. The most striking 
abnormality was acro-osteolysis3.
Acro-osteolysis describes a destructive process involving 
one or more terminal phalnges. It is seen in a number of  
systemic and local conditions, most commonly systemic 
sclerosis (SSc) (box 1).
His CXR (figure 3) showed possible hilar adenopathy and 
bilateral reticulonodular shadowing.
Spirometry confirmed a severe restrictive lung defect; FEV1 
1.27, FVC 1.27 (both <40% predicted).
Urinanalysis: showed proteinuria +, no haematuria. 
His serum creatinine was 38 micromol/l (ref. 62-106). 
Although the resources of  our hospital are limited, through 
collaboration with colleaguesoverseas we were able to define 
the patient’s immune and biochemical status in more detail. 
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Figure 1-Photograph of  both hands taken when first 
seen (18 months after symptom onset).
Sclerodactylia and camptodactylia of  all fingers except 
the thumbs can be seen. There is shortening
of  the distal phalanges and clubbing of  the nails.
Figure 2 (right and left)- X rays of  the hands taken when 
first seen (18 months after symptom onset).
The MCP joints appear normal. The PIP joints, 
particularly in digits II and III on the right hand and digit 
II and IV on the left, show cartilage loss. The DIP joints 
are difficult to see but all distal phalanges are shortened 
suggesting acro-osteolysis. It can also be noted that the 
epiphyseal plate can still be seen and may suggest that 
he is younger than 17, possibly 13 - 14 years
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His autoantibody profile was as follows: ANF negative, Anti-
ENA positive, Anti-SSA (anti Ro) strong positive, Anti-SSB 
(anti La) negative, Anti-RNP negative, Ant-SM negative 
negative, Anti-Scl 70 (antitopoisomerase 1) negative, Anti-
JO-1 negative.
Other biochemistry: calcium 2.22mmol/l (ref. 2.15-2.55), 
phosphate 1.4mmol/l (ref. 0.9-1.5), albumin 40g/l, 25(OH) 
vitamin D 62nmol/l (ref. 62-120), CRP <15.
HLA Class 1 typing by PCR-SSP: Alleles (serological equiva-
lents in brackets) : A*02 (A2), A*74 (A74), B*15 (B72), B*45 
(B45), Cw*02 (Cw2), Cw*16 (Cw16), HLA class 11 typing 
by PCR-SSP: Alleles: DRB1*11 (DR11), DRB1*13 (DR13), 
DRB3*01/02 (DR52), DRB4*=, DRB5*=, DQB1*03 
(DQ7), DQB1*06 (DQ6).
He was treated with NSAIDS, counseling and physiotherapy 
with symptomatic improvement. He reattended 18 months 
later due to deteriorating breathlessness. He was now short 
of  breath at rest and had swollen ankles. Examination re-
vealed progression of  the skin changes in his hands with
increased skin thickening, increased flexion and small ulcers 
overlying the PIP joints. He was cyanosed, O2 saturation 
77%, blood pressure 90/60 mmHg and had signs of  right 
ventricular failure. CXR showed widening of  the cardiac 
silhouette, lung fields similar to previously. Spirometry was 
essentially unchanged. Echocardiography revealed massive 
dilation of  the right ventricle and right atrium. A diagnosis 
of  cor-pulmonale was made. He did not respond to treat-
ment with diuretics and died peacefully at home 2 months 
later, under the care of  the palliative care team.
Discussion
The patients prominent clinical features were pulmonary fi-
brosis and arthropathy. He had sclerodactylia with pseudo-
clubbing4, 5 due to acro-osteolysis and/or clubbing due to 
Figure 3 Chest X ray taken when first seen at our hospital 
(18 months after symptom onset).
pulmonary disease with joint space narrowing in the proxi-
mal inter-phalyngeal (PIP) joints. These clinical features most 
closely fit with systemic sclerosis, although there were some 
a typical features. The radiograph findings are compatible 
with changes seen in scleroderma but not with rheumatoid 
arthritis (RA).
Systemic sclerosis is said to occur world-wide, although the 
only reports from Sub-Saharan Africa are from South Af-
rica2. The incidence is 10/million population/year. The male 
:female ratio is 3:1 and the peak age of  onset 30-50 years. 
Scleroderma-like syndromes can be triggered by environ-
mental exposure to vinyl chloride, silica dust, adulterated 
rape seed oil and trichloroethylene but exposure to these was 
not reported in our patient. Acro-osteolysis can be seen in a 
number of  conditions3 box 1, but in this case SSc was most 
likely. In patients with SSc, acro-osteolysis is significantly as-
sociated with digital ulceration and systemic complications, 
such as pulmonary fibrosis1. This combination of  features 
was seen in our patient. The overall prognosis for SSc is 55% 
10 year survival, with most patients dying from pulmonary, 
cardiac or renal involvement.
As in our case, 80% of  SSc patients have positive anti-nuclear 
antibodies, however the pattern of  autoantibodies in our pa-
tient is different from that typically described. Disseminated 
SSc is associated with Scl-70/antitopoisomerase 1 in up to 
50% of  cases. In this patient the ENA was positive, with a 
strong SSA signal. SSA or anti-Ro antibodies are primarily 
found in patients with SLE and Sjögren’s syndrome. Clini-
cally our patient did not have either of  these conditions. SSA 
antibodies are infrequently seen in other connective tissue 
diseases such as scleroderma, polymyositis, mixed connec-
tive tissue disease, and RA. Among patients with anti-Ro/
SSA antibodies and initially undifferentiated connective tis-
sue disease, only around 25% evolve to a more defined CTD 
(most often Sjögren’s).
Racial differences in the clinical features, auto-antibody pro-
file and genetic associations of  SSc have been described. 
Case series reported from the USA and South Africa demon-
strate that among patients with systemic sclerosis blacks are 
more likely to have progressive pulmonary interstitial fibro-
sis and worse outcomes 2,6,7. In caucasian populations SSc is 
associated with HLA A1, B8, DR3, DR5, DRw52 and DR4 
which were not present in our patient. However, our patient 
had HLA class 11 type DRB1*11. This HLA type has been 
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described in association with Scl-70 in African Americans 6 
and in association with pulmonary fibrosis in black South 
Africans with SSc8.
Conclusion
In summary this is a case of  a young patient with a rapidly 
progressive disease with several features suggesting an au-
toimmune process, particularly systemic sclerosis. However, 
he also had severe erosive arthopathy and an autoantibody 
profile suggesting Sjogren’s syndrome consistent with the
observation that CTDs in Africans may present differently 
than in Caucasians and have different underlying immune 
mechanisms. The case illustrates an important lesson; that 
some patients with a common presentation (breathlessness 
and an abnormal CXR), may have rare conditions. In our
patient a thorough history and examination revealed addi-
tional findings that pointed to the correct
diagnosis.
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